We reinvest our cash flows from our group insurance products in higher yielding assets, mitigating the impact of (i) higher interest crediting rates on, primarily, our retained asset accounts, and (ii) lower income from our derivative positions used to mitigate low interest rate margin compression.
We reinvest our cash flows from our group insurance products in higher yielding assets, mitigating the impact of (i) higher interest crediting rates, primarily on our retained asset accounts, and (ii) lower income from our derivative positions used to mitigate low interest rate margin compression.
To determine the mortgage loan ACL, we apply significant judgment to estimate expected lifetime credit loss over the contractual term of our mortgage loans adjusted for expected prepayments and any extensions; and we consider past events and current and forecasted economic conditions which are subject to inherent uncertainty and which may change from time to time.
To determine the mortgage loan ACL, we apply significant judgment to estimate expected lifetime credit loss over the contractual term of our mortgage loans adjusted for expected prepayments and any extensions; we consider past events and current and forecasted economic conditions which are subject to inherent uncertainty and which may change from time to time.
Derivatives The determination of the estimated fair value of freestanding derivatives, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing the instruments.
Freestanding Derivatives The determination of the estimated fair value of freestanding derivatives, when quoted market values are not available, is based on market standard valuation methodologies and inputs that management believes are consistent with what other market participants would use when pricing the instruments.
The estimated fair value of the reporting units tested can be impacted by unexpected changes in the legislative, regulatory and macroeconomic environment. Declines in the estimated fair value of our reporting units could result in goodwill impairments in future periods which could materially adversely affect our results of operations or financial position.
The estimated fair value of the reporting units tested can be impacted by unexpected changes in the legislative, regulatory and macroeconomic environment. Declines in the estimated fair value of our reporting units could result in goodwill impairments in future periods which could materially and adversely affect our results of operations or financial position.
Foreign currency fluctuations can result in significant variances in the financial statement line items.
Foreign currency fluctuations can result in significant variances in the financial statement line items.
Foreign currency fluctuations can result in significant variances in the financial statement line items.
Foreign currency fluctuations can result in significant variances in the financial statement line items.
Foreign currency fluctuations can result in significant variances in the financial statement line items.
Foreign currency fluctuations can result in significant variances in the financial statement line items.
We position our portfolio based on relative value and our view of the economy and financial markets. We maintain our focus on appropriate level of diversification and asset quality. We manage our investment portfolio using disciplined ALM principles, focusing on cash flow and duration to support our current and future liabilities.
We position our portfolio based on relative value and our view of the economy and financial markets. We maintain our focus on the appropriate level of diversification and asset quality. We manage our investment portfolio using disciplined ALM principles, focusing on cash flow and duration to support our current and future liabilities.
Expense ratio and direct expense ratio: • Expense ratio: other expenses, net of capitalization of DAC, divided by premiums, fees and other revenues. • Direct expense ratio: adjusted direct expenses, divided by adjusted premiums, fees and other revenues.
Expense ratio and direct expense ratio: • Expense ratio : other expenses, net of capitalization of DAC, divided by premiums, fees and other revenues. • Direct expense ratio : direct expenses divided by adjusted premiums, fees and other revenues.
Direct expenses are comprised of employee-related costs, third-party staffing costs, and general and administrative expenses. • Direct expense ratio, excluding total notable items related to direct expenses and pension risk transfers: adjusted direct expenses, excluding total notable items related to direct expenses, divided by adjusted premiums, fees and other revenues, excluding pension risk transfers.
Direct expenses are comprised of employee-related costs, third-party staffing costs, and general and administrative expenses. • Direct expense ratio, excluding total notable items related to direct expenses and pension risk transfers : direct expenses, excluding total notable items related to direct expenses, divided by adjusted premiums, fees and other revenues, excluding pension risk transfers.
Risk management is overseen and conducted through multiple Board and senior management risk committees (financial and non-financial). The risk committees are established at the enterprise, regional and local levels, as needed, to oversee capital and risk positions, approve ALM strategies and limits, and establish certain corporate risk standards and policies.
Risk management is overseen and conducted through multiple Board and senior management risk committees (financial and non-financial). The risk committees are established at the enterprise, regional and local levels, as needed, to oversee capital and risk positions, approve ALM strategies and risk limits, and establish certain corporate risk standards and policies.
For additional discussion on gross margin and interest rate assumptions, as well as the potential impact of low interest rates, see “— Results of Operations — Consolidated Results — Year Ended December 31, 2024 Compared with the Year Ended December 31, 2023 — Actuarial Assumption Review”; “Risk Factors — Economic Environment and Capital Markets Risks — We May Face Difficult Economic Conditions — Interest Rate Risks”; “Risk Factors — Business Risks — We May Be Required to Impair VOBA, VODA or VOCRA”; “Risk Factors — Business Risks — We May Be Required to Recognize an Impairment of Our Goodwill or Other Long-Lived Assets or to Establish a Valuation Allowance Against Our Deferred Income Tax Assets”; and “Risk Factors — Business Risks — We May Face Volatility, Higher Risk Management Costs, and Increased Counterparty Risk Due to Guarantees Within Certain of Our Products.” Impact of a Rising Interest Rate Environment Periods of rising U.S. interest rates may cause us to: • Reinvest investment proceeds in higher yielding assets and experience lower frequency prepayment or redemption of assets in our portfolio; • Decrease the value of our reserves related to policy liabilities; • Increase interest expense, change pension and other post-retirement benefit calculations, and change derivative cash flows and market values; and • Change our product offerings, design features, crediting rates and sales mix.
For additional discussion on gross margin and interest rate assumptions, as well as the potential impact of low interest rates, see “— Results of Operations — Consolidated Results — Year Ended December 31, 2025 Compared with the Year Ended December 31, 2024 — Actuarial Assumption Review”; “Risk Factors — Economic Environment and Capital Markets Risks — We May Face Difficult Economic Conditions — Interest Rate Risks”; “Risk Factors — Business Risks — We May Be Required to Impair VODA, VOBA, or VOCRA”; “Risk Factors — Business Risks — We May Be Required to Recognize an Impairment of Our Goodwill or Other Long-Lived Assets or to Establish a Valuation Allowance Against Our Deferred Income Tax Assets”; and “Risk Factors — Business Risks — We May Face Volatility, Higher Risk Management Costs, and Increased Counterparty Risk Due to Guarantees Within Certain of Our Products.” Impact of a Rising Interest Rate Environment Periods of rising U.S. interest rates may cause us to: • Reinvest investment proceeds in higher yielding assets and experience lower frequency prepayment or redemption of assets in our portfolio; • Decrease the value of our reserves related to policy liabilities; • Increase interest expense, change pension and other post-retirement benefit calculations, and change derivative cash flows and market values; and • Change our product offerings, design features, crediting rates and sales mix.
Adjusted Earnings - Increased $339 million on a reported basis, primarily due to the following business drivers: Foreign Currency - Decreased adjusted earnings by $34 million: • Japanese yen and Korean won weakened against the U.S. dollar Market Factors - Increased adjusted earnings by $193 million: • Variable investment income increased - higher returns on private equity funds • Recurring investment income increased - higher yields on fixed income securities Partially offset by: • Higher average interest crediting rates on investment-type and certain insurance products Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $89 million: • Higher surrender charges in Japan • Favorable change from refinements to certain insurance assets and liabilities in both years Taxes - Increased adjusted earnings by $41 million: • Favorable change in Japan - lower premium tax due to lower sales and tax benefits from higher foreign earnings taxed at lower rates in 2024 • Favorable change in Korea - tax benefits due to lower dividend withholding tax as a result of a rate decrease and a tax audit settlement in 2024 Notable Items - Increased adjusted earnings by $53 million on a reported basis: • 2024 notable item - unfavorable impact of $41 million - actuarial assumption review • 2023 notable item - unfavorable impact of $94 million - actuarial assumption review 72 Table of Contents Latin America Business Overview.
Adjusted Earnings - Increased $339 million on a reported basis, primarily due to the following business drivers: Foreign Currency - Decreased adjusted earnings by $34 million: • Japanese yen and Korean won weakened against the U.S. dollar Market Factors - Increased adjusted earnings by $193 million: • Variable investment income increased - higher returns on private equity funds • Recurring investment income increased - higher yields on fixed income securities Partially offset by: • Higher average interest crediting rates on investment-type and certain insurance products Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $89 million: • Higher surrender charges in Japan • Favorable change from refinements to certain insurance assets and liabilities in both years Taxes - Increased adjusted earnings by $41 million: • Favorable change in Japan - lower premium tax due to lower sales and tax benefits from higher foreign earnings taxed at lower rates in 2024 • Favorable change in Korea - tax benefits due to lower dividend withholding tax as a result of a rate decrease and a tax audit settlement in 2024 Notable Items - Increased adjusted earnings by $53 million on a reported basis: • 2024 notable item - unfavorable impact of $41 million - actuarial assumption review • 2023 notable item - unfavorable impact of $94 million - actuarial assumption review 79 Table of Contents Latin America Business Overview.
Adjusted Earnings - Decreased $41 million primarily due to the following business drivers: Market Factors - Decreased adjusted earnings by $97 million: • Higher average interest crediting rates primarily on investment-type products Largely offset by: • Variable investment income increased - higher returns on private equity funds • Recurring investment income increased - higher yields on fixed income securities and mortgage loans, partially offset by lower income on derivatives Volume Growth - Increased adjusted earnings by $62 million: • Positive flows from pension risk transfer transactions and funding agreement issuances resulted in higher average invested assets Largely offset by: • Increase in interest credited expenses on long duration products Underwriting and Other Insurance Adjustments - Decreased adjusted earnings by $32 million: • Unfavorable refinements to certain insurance liabilities Expenses - Decreased adjusted earnings by $39 million: • Higher expenses, including certain employee-related costs Notable Items - Increased adjusted earnings by $43 million: • 2024 notable item - favorable impact of $104 million - actuarial assumption review • 2023 notable item - favorable impact of $61 million - actuarial assumption review 71 Table of Contents Asia Business Overview.
Adjusted Earnings - Decreased $41 million primarily due to the following business drivers: Market Factors - Decreased adjusted earnings by $97 million: • Higher average interest crediting rates primarily on investment-type products Largely offset by: • Variable investment income increased - higher returns on private equity funds • Recurring investment income increased - higher yields on fixed income securities and mortgage loans, partially offset by lower income on derivatives Volume Growth - Increased adjusted earnings by $62 million: • Positive flows from pension risk transfer transactions and funding agreement issuances resulted in higher average invested assets Largely offset by: • Increase in interest credited expenses on long-duration products Underwriting and Other Insurance Adjustments - Decreased adjusted earnings by $32 million: • Unfavorable refinements to certain insurance liabilities Expenses - Decreased adjusted earnings by $39 million: • Higher expenses, including certain employee-related costs Notable Items - Increased adjusted earnings by $43 million: • 2024 notable item - favorable impact of $104 million - actuarial assumption review • 2023 notable item - favorable impact of $61 million - actuarial assumption review 77 Table of Contents Asia Business Overview.
Adjusted Earnings - Increased $41 million on a reported basis, primarily due to the following business drivers: Foreign Currency - Decreased adjusted earnings by $49 million: • Chilean and Mexican peso weakened against the U.S. dollar Volume Growth - Increased adjusted earnings by $95 million: • Strong sales of single premium immediate annuities in Chile resulted in higher average invested assets • Higher sales, primarily in Mexico and Chile Partially offset by: • Increase in interest credited expenses on long duration products Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $22 million: • Favorable refinements to certain insurance liabilities primarily in Chile and Mexico Expenses - Decreased adjusted earnings by $13 million: • Higher corporate-related and various other operating expenses, primarily in Mexico and Chile Other - Decreased adjusted earnings by $15 million, includes • Higher amortization of DAC Notable Items - Increased adjusted earnings by $4 million: • 2024 notable item - favorable impact of $4 million - actuarial assumption review 73 Table of Contents EMEA Business Overview .
Adjusted Earnings - Increased $41 million on a reported basis, primarily due to the following business drivers: Foreign Currency - Decreased adjusted earnings by $49 million: • Chilean and Mexican peso weakened against the U.S. dollar Volume Growth - Increased adjusted earnings by $95 million: • Strong sales of single premium immediate annuities in Chile resulted in higher average invested assets • Higher sales, primarily in Mexico and Chile Partially offset by: • Increase in interest credited expenses on long-duration products Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $22 million: • Favorable refinements to certain insurance liabilities primarily in Chile and Mexico Expenses - Decreased adjusted earnings by $13 million: • Higher corporate-related and various other operating expenses, primarily in Mexico and Chile Other - Decreased adjusted earnings by $15 million, includes • Higher amortization of DAC Notable Items - Increased adjusted earnings by $4 million: • 2024 notable item - favorable impact of $4 million - actuarial assumption review 81 Table of Contents EMEA Business Overview .
We establish portfolio guidelines that define ranges and limits related to asset allocation, interest rate risk, liquidity, concentration and other risks for each major business segment, legal entity or insurance product group. These guidelines support implementation of investment strategies used to adequately fund our liabilities within acceptable levels of risk.
We establish portfolio guidelines that define ranges and limits related to asset allocation, interest rate risk, liquidity, concentration and other risks for each major business segment, legal entity and insurance product group. These guidelines support implementation of investment strategies used to adequately fund our liabilities within acceptable levels of risk.
Additional details regarding certain of our primary sources of liquidity and capital are included in the Notes to the Consolidated Financial Statements referenced in “— Overview” and are discussed below. The diversity of our global funding sources enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds.
Additional details regarding certain of our primary sources and uses of liquidity and capital are included in the Notes to the Consolidated Financial Statements referenced in “— Overview” and are discussed below. The diversity of our global funding sources enhances our funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds.
For such contracts, original assumptions developed at the time of issue are locked-in and used in all future liability calculations. An additional liability would be required if the resulting liabilities are not adequate to provide for future benefits and expenses (i.e., there is a premium deficiency).
For such contracts, original assumptions developed at the time of issue are locked-in and used in all future liability calculations. An additional reserve would be required if the resulting liabilities are not adequate to provide for future benefits and expenses (i.e., there is a premium deficiency).
Adjusted Earnings - Decreased $49 million primarily due to the following business drivers: Market Factors - Decreased adjusted earnings by $27 million: • Recurring investment income decreased - lower income on derivatives, partially offset by higher yields on fixed income securities Volume Growth - Increased adjusted earnings by $18 million: • Growth in both core and voluntary products Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $88 million: • Favorable mortality - primarily due to lower claims incidence in our life business • Favorable change from refinements to certain insurance and other liabilities in both years Partially offset by: • Unfavorable morbidity - (i) higher incidence in the accident & health business, (ii) higher claims in vision, and (iii) higher utilization and the impact of prior year development in dental, partially offset by (a) favorable claims experience and rate actions in our pet insurance business and (b) higher recoveries and a favorable reserve adjustment in 2024 in our disability business Expenses - Decreased adjusted earnings by $43 million: • Higher legal plan utilization and higher technology, employee-related and various other operating expenses exceeded the corresponding increase in adjusted premiums, fees and other revenues Notable Items - Decreased adjusted earnings by $85 million: • 2024 notable items - unfavorable impact of $58 million - actuarial assumption review and other insurance adjustments, which includes an unfavorable refinement on certain life policies • 2023 notable item - favorable impact of $27 million - actuarial assumption review 70 Table of Contents Retirement & Income Solutions Business Overview.
Adjusted Earnings - Decreased $49 million primarily due to the following business drivers: Market Factors - Decreased adjusted earnings by $27 million: • Recurring investment income decreased - lower income on derivatives, partially offset by higher yields on fixed income securities Volume Growth - Increased adjusted earnings by $18 million: • Growth in both core and voluntary products Underwriting and Other Insurance Adjustments - Increased adjusted earnings by $88 million: • Favorable mortality - primarily due to lower claims incidence in our life business • Favorable change from refinements to certain insurance and other liabilities in both years Partially offset by: • Unfavorable morbidity - (i) higher incidence in the accident & health business, (ii) higher claims in vision, and (iii) higher utilization and the impact of prior year development in dental, partially offset by (a) favorable claims experience and rate actions in our pet insurance business and (b) higher recoveries and a favorable reserve adjustment in 2024 in our disability business Expenses - Decreased adjusted earnings by $43 million: • Higher legal plan utilization and higher technology, employee-related and various other operating expenses exceeded the corresponding increase in adjusted premiums, fees and other revenues Notable Items - Decreased adjusted earnings by $85 million: • 2024 notable items - unfavorable impact of $58 million - actuarial assumption review and other insurance adjustments, which includes an unfavorable refinement on certain life policies • 2023 notable item - favorable impact of $27 million - actuarial assumption review Retirement & Income Solutions Business Overview.
See “— Summary of Critical Accounting Estimates — Derivatives” for further information on the estimates and assumptions that affect derivatives. See also “Quantitative and Qualitative Disclosures About Market Risk — Management of Market Risk Exposures — Hedging Activities” for more information about our use of derivatives by major hedge program.
See “— Summary of Critical Accounting Estimates — Freestanding Derivatives” for further information on the estimates and assumptions that affect derivatives. See also “Quantitative and Qualitative Disclosures About Market Risk — Management of Market Risk Exposures — Hedging Activities” for more information about our use of derivatives by major hedge program.
Such dividends are subject to local insurance regulatory requirements, as discussed in “— Liquidity and Capital Sources — Dividends from Subsidiaries.” See “— Consolidated Company Outlook” for the targeted level of liquid assets at the holding companies.
Such dividends are subject to local insurance regulatory requirements, as discussed in “— Liquidity and Capital Sources and Uses — Dividends from Subsidiaries.” See “— Consolidated Company Outlook” for the targeted level of liquid assets at the holding companies.
See Note 12 of the Notes to the Consolidated Financial Statements for: • A comprehensive description of the nature of our derivatives, including the strategies for which derivatives are used in managing various risks. • Information about the primary underlying risk exposure, gross notional amount, and estimated fair value of our derivatives by type of hedge designation, excluding embedded derivatives held at December 31, 2024 and 2023. • The statement of operations effects of derivatives in net investments in foreign operations, cash flow, fair value, or nonqualifying hedging relationships for the years ended December 31, 2024, 2023 and 2022.
See Note 12 of the Notes to the Consolidated Financial Statements for: • A comprehensive description of the nature of our derivatives, including the strategies for which derivatives are used in managing various risks. • Information about the primary underlying risk exposure, gross notional amount, and estimated fair value of our derivatives by type of hedge designation, excluding embedded derivatives held at December 31, 2025 and 2024. • The statement of operations effects of derivatives in net investments in foreign operations, cash flow, fair value, or nonqualifying hedging relationships for the years ended December 31, 2025, 2024 and 2023.
In addition to proactive management strategies, businesses within our Latin America, EMEA, and Asia (exclusive of our Japan business) segments help alleviate impacts to our consolidated results given their limited U.S. interest rate sensitivity.
In addition to proactive management strategies, businesses within our Latin America, EMEA, Asia (exclusive of our Japan business) and MIM segments help alleviate impacts to our consolidated results given their limited U.S. interest rate sensitivity.
The most critical estimates include those used in determining: (i) future policy benefit liabilities (“FPBs”), MRBs, and the accounting for reinsurance; (ii) estimated fair values of investments in the absence of quoted market values; (iii) investment allowance for credit loss (“ACL”) and impairments; (iv) estimated fair values of freestanding derivatives; (v) measurement of goodwill and related impairment; (vi) measurement of employee benefit plan liabilities; (vii) measurement of income taxes and the valuation of deferred tax assets; and (viii) liabilities for litigation and regulatory matters.
The most critical estimates include those used in determining: (i) future policy benefit liabilities (“FPBs”), MRBs, and reinsurance recoverables; (ii) estimated fair values of investments in the absence of quoted market values; (iii) investment allowance for credit loss (“ACL”) and impairments; (iv) estimated fair values of freestanding derivatives; (v) measurement of goodwill and related impairment; (vi) measurement of employee benefit plan liabilities; (vii) measurement of income taxes and the valuation of deferred tax assets; and (viii) liabilities for litigation and regulatory matters.
These ratings modifiers are generally assigned in connection with certain events such as potential mergers, acquisitions, dispositions or material changes in a company’s results, in order for the rating agency to perform its analysis to fully determine the rating implications of the event. Our insurer financial strength ratings at the date of this filing are indicated in the following table.
These ratings modifiers are generally assigned in connection with certain events such as potential mergers, acquisitions, dispositions or material changes in a company’s results, in order for the rating agency to perform its analysis to fully determine the rating implications of the event. 109 Table of Contents Our insurer financial strength ratings at the date of this filing are indicated in the following table.
Market conditions including changes in interest rates, equity indices, market volatility and foreign currency exchange rates, variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income, and changes in our nonperformance risk could materially affect OCI.
Market conditions including changes in interest rates, equity indices, market volatility and foreign currency exchange rates, variations in actuarial assumptions regarding policyholder behavior, mortality and risk margins related to non-capital market inputs, may result in significant fluctuations in the estimated fair value of the guarantees that could materially affect net income, and changes in the Company’s nonperformance risk could materially affect OCI.
As shown in the following section, less than 1% of our fixed maturity securities AFS were valued using non-binding quotations from independent brokers at December 31, 2024. Senior management, independent of the trading and investing functions, is responsible for the oversight of control systems and valuation policies for securities, mortgage loans, real estate and derivatives.
As shown in the following section, less than 1% of our fixed maturity securities AFS were valued using non-binding quotations from independent brokers at December 31, 2025. Senior management, independent of the trading and investing functions, is responsible for the oversight of control systems and valuation policies for securities, mortgage loans, real estate and derivatives.
Best Fitch Moody’s S&P Ratings Structure “A++ (Superior)” to “S (Suspended)” “AAA (Exceptionally Strong)” to “C (Distressed)” “Aaa (Highest Quality)” to “C (Lowest Rated)” “AAA (Extremely Strong)” to “SD (Selective Default)” or “D (Default)” American Life Insurance Company NR NR A1 AA- 5th of 21 4th of 21 Metropolitan Life Insurance Company A+ AA- Aa3 AA- 2nd of 16 4th of 19 4th of 21 4th of 21 MetLife Insurance K.K.
Best Fitch Moody’s S&P Ratings Structure “A++ (Superior)” to “S (Suspended)” “AAA (Exceptionally Strong)” to “C (Distressed)” “Aaa (Highest Quality)” to “C (Lowest Rated)” “AAA (Extremely Strong)” to “SD (Selective Default)” or “D (Default)” American Life Insurance Company Not Rated Not Rated A1 AA- 5th of 21 4th of 21 Metropolitan Life Insurance Company A+ AA- Aa3 AA- 2nd of 16 4th of 19 4th of 21 4th of 21 MetLife Insurance K.K.
Our Latin America, EMEA, and Asia (exclusive of our Japan business) segments are excluded given their limited U.S. interest rate sensitivity.
Our Latin America, EMEA, Asia (exclusive of our Japan business) and MIM segments are excluded given their limited U.S. interest rate sensitivity.
While most of these contracts are either at or slightly above their minimum crediting rate, we use interest rate derivatives to manage the gross margin compression risk. 51 Table of Contents Our long-term care business experiences gross margin compression as we cannot reduce interest crediting rates for established claim reserves.
While most of these contracts are either at or slightly above their minimum crediting rate, we use interest rate derivatives to manage the gross margin compression risk. 52 Table of Contents Our long-term care business experiences gross margin compression as we cannot reduce interest crediting rates for established claim reserves.
See “— Consolidated Results — Adjusted Earnings Available to Common Shareholders.” Taxes - Favorable change in effective tax rate - 21% in 2024 compared to 26% in 2023: • 2024 effective tax rate on income before provision for income tax was equal to the U.S. statutory rate of 21% primarily due to tax benefits from: ◦ Non-taxable investment income ◦ Low income housing and other tax credits, partially offset by the impact of tax equity investments now accounted for under the proportional amortization method ◦ Corporate tax deduction for stock compensation Offset by tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates ◦ Adjustments related to prior years’ taxes • 2023 effective tax rate on income before provision for income tax was 26% compared to the U.S. statutory rate of 21% primarily due to tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates ◦ Non-taxable investment loss Partially offset by tax credits from: ◦ Low income housing and other tax credits ◦ Non-taxable investment income ◦ Corporate tax deduction for stock compensation __________________ (1) See “— Investments — Overview” and “— Investments — Investment Portfolio Results — Net Investment Gains (Losses)” for information regarding management of our investment portfolio.
See “— Consolidated Results — Adjusted Earnings Available to Common Shareholders.” Taxes - Favorable change in effective tax rate - 21% in 2024 compared to 26% in 2023: • 2024 effective tax rate on income before provision for income tax was equal to the U.S. statutory rate of 21% primarily due to tax benefits from: ◦ Non-taxable investment income ◦ Low income housing and other tax credits, partially offset by the impact of tax equity investments accounted for under the proportional amortization method in 2024 ◦ Corporate tax deduction for stock compensation Offset by tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates ◦ Adjustments related to prior years’ taxes • 2023 effective tax rate on income before provision for income tax was 26% compared to the U.S. statutory rate of 21% primarily due to tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates ◦ Non-taxable investment loss Partially offset by tax credits from: ◦ Low income housing and other tax credits 66 Table of Contents ◦ Non-taxable investment income ◦ Corporate tax deduction for stock compensation __________________ (1) See “— Investments — Overview” and “— Investments — Investment Portfolio Results — Net Investment Gains (Losses)” for information regarding management of our investment portfolio.
Adjusted Earnings - Increased $18 million on a reported basis, primarily due to the following business drivers: Foreign Currency - Decreased adjusted earnings by $12 million: • Turkish lira and Egyptian pound weakened against the U.S. dollar Market Factors - Increased adjusted earnings by $29 million: • Recurring investment income increased - higher yields on fixed income securities Volume Growth - Increased adjusted earnings by $51 million: • Increase in sales and business growth of: ◦ Credit life and pension businesses in Turkey and Romania ◦ Corporate solutions business in the Gulf, the U.K. and Egypt ◦ Accident & health business across the region Underwriting and Other Insurance Adjustments - Decreased adjusted earnings by $4 million: • Unfavorable change from refinements to certain insurance liabilities in both years Partially offset by: • Favorable underwriting experience across the region Expenses - Decreased adjusted earnings by $36 million: • Higher direct expenses, including employee-related costs and various other operating expenses across the region Taxes - Increased adjusted earnings by $13 million • Tax-related adjustments in both years Notable Items - Decreased adjusted earnings by $23 million on a reported basis: • 2024 notable item - unfavorable impact of $5 million - actuarial assumption review • 2023 notable items - favorable impact of $18 million - actuarial assumption review and other insurance adjustments 74 Table of Contents MetLife Holdings Business Overview.
Adjusted Earnings - Increased $18 million on a reported basis, primarily due to the following business drivers: Foreign Currency - Decreased adjusted earnings by $12 million: • Turkish lira and Egyptian pound weakened against the U.S. dollar Market Factors - Increased adjusted earnings by $29 million: • Recurring investment income increased - higher yields on fixed income securities Volume Growth - Increased adjusted earnings by $51 million: • Increase in sales and business growth of: ◦ Credit life and pension businesses in Turkey and Romania ◦ Corporate solutions business in the Gulf, the U.K. and Egypt ◦ Accident & health business across the region Underwriting and Other Insurance Adjustments - Decreased adjusted earnings by $4 million: • Unfavorable change from refinements to certain insurance liabilities in both years Partially offset by: • Favorable underwriting experience across the region Expenses - Decreased adjusted earnings by $36 million: • Higher direct expenses, including employee-related costs and various other operating expenses across the region Taxes - Increased adjusted earnings by $13 million • Tax-related adjustments in both years Notable Items - Decreased adjusted earnings by $23 million on a reported basis: • 2024 notable item - unfavorable impact of $5 million - actuarial assumption review • 2023 notable items - favorable impact of $18 million - actuarial assumption review and other insurance adjustments MetLife Investment Management Business Overview.
Future Adoption of Accounting Pronouncements See Note 1 of the Notes to the Consolidated Financial Statements. 107 Table of Contents Non-GAAP and Other Financial Disclosures In this report, the Company presents certain measures of its performance on a consolidated and segment basis that are not calculated in accordance with GAAP.
Future Adoption of Accounting Pronouncements See Note 1 of the Notes to the Consolidated Financial Statements. 118 Table of Contents Non-GAAP and Other Financial Disclosures In this report, the Company presents certain measures of its performance on a consolidated and segment basis that are not calculated in accordance with GAAP.
The valuation of these MRBs also includes an adjustment for our nonperformance risk and risk margins for non-capital market inputs.
The valuation of these MRBs also includes an adjustment for nonperformance risk and risk margins for non-capital market inputs.
Additional details regarding certain of MetLife, Inc.’s primary uses of liquidity and capital are included in “— The Company — Liquidity and Capital Uses,” the Notes to the Consolidated Financial Statements referenced in “— Overview” and are discussed below. 106 Table of Contents Based on our analysis and comparison of our current and future cash inflows from the dividends we receive from subsidiaries that are permitted to be paid without prior insurance regulatory approval, our investment portfolio and other cash flows and anticipated access to the capital markets, we believe there will be sufficient liquidity and capital to enable MetLife, Inc. to make payments on debt, pay cash dividends on its common and preferred stock, contribute capital to its subsidiaries, repurchase its common stock and certain of its other securities, pay all general operating expenses and meet its cash needs under current market conditions and reasonably possible stress scenarios.
Additional details regarding certain of MetLife, Inc.’s primary sources of liquidity and capital are included in “— The Company — Liquidity and Capital Sources and Uses” and the Notes to the Consolidated Financial Statements referenced in “— Overview” and are discussed below. 116 Table of Contents Based on our analysis and comparison of our current and future cash inflows from the dividends we receive from subsidiaries that are permitted to be paid without prior insurance regulatory approval, our investment portfolio and other cash flows and anticipated access to the capital markets, we believe there will be sufficient liquidity and capital to enable MetLife, Inc. to make payments on debt, pay cash dividends on its common and preferred stock, contribute capital to its subsidiaries, repurchase its common stock and certain of its other securities, pay all general operating expenses and meet its cash needs under current market conditions and reasonably possible stress scenarios.
Liabilities for unpaid claims are estimated based upon our historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs. 53 Table of Contents Traditional non-participating long-duration and limited-payment contracts comprise the majority of MetLife’s FPBs, inclusive of deferred profit liabilities, as described in Note 4 of the Notes to the Consolidated Financial Statements.
Liabilities for unpaid claims are estimated based upon our historical experience and other actuarial assumptions that consider the effects of current developments, anticipated trends and risk management programs. Traditional non-participating long-duration and limited-payment contracts comprise the majority of MetLife’s FPBs, inclusive of deferred profit liabilities, as described in Note 4 of the Notes to the Consolidated Financial Statements.
(2) All sensitivities exclude potential changes in our future premium rate assumptions. (3) For products which are subject to morbidity risk, MetLife applied sensitivities to the incidence rate assumptions only. (4) For MetLife Holdings long-term care products, the lapse impacts include mortality as both mortality and lapse result in termination of these contracts without any additional benefit payment.
(2) All sensitivities exclude potential changes in our future premium rate assumptions. (3) For products which are subject to morbidity risk, MetLife applied sensitivities to the incidence rate assumptions only. (4) For long-term care and individual disability products, the lapse impacts include mortality as both mortality and lapse result in termination of these contracts without any additional benefit payment.
(2) Includes primarily securities collateralized by broadly syndicated bank loans. 88 Table of Contents CMBS Our CMBS portfolio is comprised primarily of conduit, single asset and single borrower securities. Conduit securities are collateralized by many commercial mortgage loans and are broadly diversified by property type, borrower and geography.
(2) Includes primarily securities collateralized by broadly syndicated bank loans. 98 Table of Contents CMBS Our CMBS portfolio is comprised primarily of conduit, single asset and single borrower securities. Conduit securities are collateralized by many commercial mortgage loans and are broadly diversified by property type, borrower and geography.
See Note 9 of the Notes to the Consolidated Financial Statements for additional information on our reinsurance programs. Traditional participating contracts comprise a significant portion of MetLife’s FPBs, as described in Note 4 of the Notes to the Consolidated Financial Statements.
See Note 9 of the Notes to the Consolidated Financial Statements for additional information on our reinsurance transactions. Traditional participating contracts comprise a significant portion of MetLife’s FPBs, as described in Note 4 of the Notes to the Consolidated Financial Statements.
This portfolio did not have any exposure to any single issuer in excess of 1% of total investments at either December 31, 2024 or 2023. The top 10 holdings comprised 1% of total investments at both December 31, 2024 and 2023.
This portfolio did not have any exposure to any single issuer in excess of 1% of total investments at either December 31, 2025 or 2024. The top 10 holdings comprised 1% of total investments at both December 31, 2025 and 2024.
In our group life and disability businesses, premiums increase as compensation levels of our customers’ employees increase. However, during inflationary periods with rising interest rates, the value of fixed income investments falls which could increase realized and unrealized losses, resulting in additional deferred tax assets that may not be realizable.
In our group life and disability businesses, premiums increase as compensation levels of our customers’ employees increase. For example, during inflationary periods with rising interest rates, the value of fixed income investments falls which could increase realized and unrealized losses, resulting in additional deferred tax assets that may not be realizable.
This provides repricing flexibility to mitigate the negative impact of reinvesting in lower yielding assets. 50 Table of Contents Our retained asset accounts experience gross margin compression due to minimum crediting rate guarantees. Additionally, we experience gross margin compression from our disability policy claim reserves for which crediting rates cannot be reduced.
This provides repricing flexibility to mitigate the negative impact of reinvesting in lower yielding assets. Our retained asset accounts experience gross margin compression due to minimum crediting rate guarantees. Additionally, we experience gross margin compression from our disability policy claim reserves for which crediting rates cannot be reduced.
Our intent is to match the timing and amount of liability cash outflows with invested assets that have cash inflows of comparable timing and amount, while optimizing risk-adjusted investment income and risk-adjusted total return. Our investment portfolio is heavily weighted toward fixed income investments, with the vast majority of our portfolio invested in fixed maturity securities AFS and mortgage loans.
Our intent is to match the timing and amount of liability cash outflows with invested assets that have cash inflows of comparable timing and amount, while optimizing risk-adjusted investment income and risk-adjusted total return. Our investment portfolio is heavily weighted toward fixed income investments, with most of our portfolio invested in fixed maturity securities AFS and mortgage loans.
Based on our investment portfolios and expected cash flows, only a small portion of invested assets are subject to reinvestment risk through 2027. Rising Interest Rate Scenario .
Based on our investment portfolios and expected cash flows, only a small portion of invested assets are subject to reinvestment risk through 2028. Rising Interest Rate Scenario .
If no NAIC designation is available, then, as permitted by the NAIC, an internally developed designation is used. NAIC designations for non-agency RMBS and CMBS are based on a modeling methodology that estimates security level expected losses under a variety of economic scenarios.
If no NAIC designation is available, then, as permitted by the NAIC, an internally developed designation is used. 93 Table of Contents NAIC designations for non-agency RMBS and CMBS are based on a modeling methodology that estimates security level expected losses under a variety of economic scenarios.
In addition, adjusted earnings available to common shareholders excludes the impact of preferred stock redemption premium, which is reported as a reduction to net income (loss) available to MetLife, Inc.’s common shareholders. 108 Table of Contents Return on equity, allocated equity and related measures: • Total MetLife, Inc.’s adjusted common stockholders’ equity : total MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), MRBs instrument-specific credit risk remeasurement gains (losses) and defined benefit plans adjustment components of AOCI (AOCI other than FCTA) and the estimated fair value of certain ceded reinsurance-related embedded derivatives, all net of income tax. • Total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items : total MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), MRBs instrument-specific credit risk remeasurement gains (losses) and defined benefit plans adjustment components of AOCI (AOCI other than FCTA), the estimated fair value of certain ceded reinsurance-related embedded derivatives and total notable items, all net of income tax. • Return on MetLife, Inc.’s common stockholders’ equity : net income (loss) available to MetLife, Inc.’s common shareholders divided by MetLife, Inc.’s average common stockholders’ equity. • Adjusted return on MetLife, Inc.’s common stockholders’ equity : adjusted earnings available to common shareholders divided by MetLife, Inc.’s average adjusted common stockholders’ equity. • Adjusted return on MetLife, Inc.’s common stockholders’ equity, excluding total notable items : adjusted earnings available to common shareholders, excluding total notable items, divided by MetLife, Inc.’s average adjusted common stockholders’ equity, excluding total notable items. • Allocated equity : the portion of total MetLife, Inc.’s adjusted common stockholders’ equity that management allocates to each of its segments based on local capital requirements and economic capital.
In addition, adjusted earnings available to common shareholders excludes the impact of preferred stock redemption premium, which is reported as a reduction to net income (loss) available to MetLife, Inc.’s common shareholders. 119 Table of Contents Return on equity, allocated equity and related measures: • Total MetLife, Inc.’s adjusted common stockholders’ equity : total MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), MRBs instrument-specific credit risk remeasurement gains (losses) and defined benefit plans adjustment components of accumulated other comprehensive income (loss) (“AOCI”) and the estimated fair value of certain ceded reinsurance-related embedded derivatives, all net of income tax. • Total MetLife, Inc.’s adjusted common stockholders’ equity, excluding total notable items : total MetLife, Inc.’s common stockholders’ equity, excluding unrealized investment gains (losses), net of related offsets, deferred gains (losses) on derivatives, future policy benefits discount rate remeasurement gains (losses), MRBs instrument-specific credit risk remeasurement gains (losses) and defined benefit plans adjustment components of AOCI, the estimated fair value of certain ceded reinsurance-related embedded derivatives and total notable items, all net of income tax. • Return on MetLife, Inc.’s common stockholders’ equity : net income (loss) available to MetLife, Inc.’s common shareholders divided by MetLife, Inc.’s average common stockholders’ equity. • Adjusted return on MetLife, Inc.’s common stockholders’ equity : adjusted earnings available to common shareholders divided by MetLife, Inc.’s average adjusted common stockholders’ equity. • Adjusted return on MetLife, Inc.’s common stockholders’ equity, excluding total notable items : adjusted earnings available to common shareholders, excluding total notable items, divided by MetLife, Inc.’s average adjusted common stockholders’ equity, excluding total notable items. • Allocated equity : the portion of total MetLife, Inc.’s adjusted common stockholders’ equity that management allocates to each of its segments based on local capital requirements and economic capital.
Our real estate investment portfolio had appreciated to a $3.7 billion and $4.8 billion unrealized gain position at December 31, 2024 and 2023, respectively. We continuously monitor and assess our real estate investments for impairment when facts and circumstances indicate that the real estate may be impaired.
Our real estate investment portfolio had appreciated to a $3.4 billion and $3.7 billion unrealized gain position at December 31, 2025 and 2024, respectively. We continuously monitor and assess our real estate investments for impairment when facts and circumstances indicate that the real estate may be impaired.
Notable items represent a positive (negative) impact to adjusted earnings available to common shareholders. 109 Table of Contents • The Company uses a measure of free cash flow to facilitate an understanding of its ability to generate cash for reinvestment into its businesses or use in non-mandatory capital actions.
Notable items represent a positive (negative) impact to adjusted earnings available to common shareholders. • The Company uses a measure of free cash flow to facilitate an understanding of its ability to generate cash for reinvestment into its businesses or use in non-mandatory capital actions.
Notable items also include certain items regardless of the extent anticipated in the business plan, to help investors have a better understanding of MetLife’s results and to evaluate and forecast those results.
Notable items also include certain items regardless of the extent anticipated in the business plan, to help investors have a better understanding of the Company’s results and to evaluate and forecast those results.
Also, see Note 13 of the Notes to the Consolidated Financial Statements for additional information on the fair value measurement of MRBs. 56 Table of Contents Estimated Fair Value of Investments The estimated fair values of our investments are based on unadjusted quoted prices for identical investments in active markets that are readily and regularly obtainable.
Also, see Note 13 of the Notes to the Consolidated Financial Statements for additional information on the fair value measurement of MRBs. Estimated Fair Value of Investments The estimated fair values of our investments are based on unadjusted quoted prices for identical investments in active markets that are readily and regularly obtainable.
The methodologies, assumptions and inputs utilized are described in Note 13 of the Notes to the Consolidated Financial Statements. For the vast majority of our investments, sensitivity analysis regarding unobservable inputs is not necessary or appropriate, as they are valued using quoted prices, as described above.
The methodologies, assumptions and inputs utilized are described in Note 13 of the Notes to the Consolidated Financial Statements. For most of our investments, sensitivity analysis regarding unobservable inputs is not necessary or appropriate, as they are valued using quoted prices, as described above.
Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $1.2 billion, or 2%, compared to 2023, primarily due to growth in both core and voluntary products in the Group Benefits segment and strong sales and solid persistency across the region in the Latin America segment, partially offset by the expected decline in the MetLife Holdings segment from business run-off.
Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $1.2 billion, or 2%, compared to 2023, primarily due to growth in both core and voluntary products in the Group Benefits segment and strong sales and solid persistency across the region in the Latin America segment, partially offset by the decline in Corporate & Other from business run-off.
Changes in tax laws and/or statutory tax rates in countries in which we operate could have an impact on our valuation of net deferred tax assets.
Changes in tax laws or interpretations of such laws and/or statutory tax rates in countries in which we operate could have an impact on our valuation of net deferred tax assets.
The portion of these properties located in Japan, Washington, D.C. and Georgia were 28%, 9% and 8%, respectively, at December 31, 2024, at carrying value. Other Limited Partnership Interests Other limited partnership interests are comprised of investments in private funds, including private equity funds and hedge funds.
The portion of these properties located in Japan, Washington, D.C. and Georgia were 28%, 9% and 8%, respectively, at December 31, 2025, at carrying value. Other Limited Partnership Interests Other limited partnership interests are comprised of investments in private funds, including private equity funds.
In the absence of such market-based evidence, management’s best estimate is used. We have reviewed the significance and observability of inputs used in the valuation methodologies to determine the appropriate fair value hierarchy level for each of our securities.
In the absence of such market-based evidence, management’s best estimate is used. 92 Table of Contents We have reviewed the significance and observability of inputs used in the valuation methodologies to determine the appropriate fair value hierarchy level for each of our securities.
Given the amount of plan assets as of December 31, 2023, the beginning of the measurement year, if we had assumed an expected rate of return for both our pension and other postretirement benefit plans that was 100 basis points higher or 100 basis points lower than the rates we assumed, the change in our net periodic benefit costs in 2024 would have been as follows: Year Ended December 31, 2024 Increase/(Decrease) in Net Periodic Pension Cost Increase/(Decrease) in Net Other Postretirement Benefit Cost (In millions) Increase in expected rate of return by 100 bps $ (79) $ (13) Decrease in expected rate of return by 100 bps $ 79 $ 13 This table considers only changes in our assumed long-term rate of return given the level and mix of invested assets at the beginning of the year, without consideration of possible changes in any of the other assumptions described above that could ultimately accompany any changes in our assumed long-term rate of return.
Given the amount of plan assets as of December 31, 2024, the beginning of the measurement year, if we had assumed an expected rate of return for both our pension and other postretirement benefit plans that was 100 basis points higher or 100 basis points lower than the rates we assumed, the change in our net periodic benefit costs in 2025 would have been as follows: Year Ended December 31, 2025 Increase/(Decrease) in Net Periodic Pension Cost Increase/(Decrease) in Net Other Postretirement Benefit Cost (In millions) Increase in expected rate of return by 100 bps $ (76) $ (7) Decrease in expected rate of return by 100 bps $ 76 $ 7 The above table considers only changes in our assumed long-term rate of return given the level and mix of invested assets at the beginning of the year, without consideration of possible changes in any of the other assumptions described above that could ultimately accompany any changes in our assumed long-term rate of return.
The nonperformance risk adjustment, which is captured as a spread over the risk-free rate in determining the discount rate to discount the cash flows of the liability, is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps.
For direct and assumed MRBs, the nonperformance risk adjustment, which is captured as a spread over the risk-free rate in determining the discount rate to discount the cash flows of the liability, is determined by taking into consideration publicly available information relating to spreads in the secondary market for MetLife, Inc.’s debt, including related credit default swaps.
If there had been a 1% increase in the global effective income tax rate, the change would have resulted in an approximate $ 132 million increase in the net deferred income tax asset balance at December 31, 2024. See Notes 1 and 22 of the Notes to the Consolidated Financial Statements for additional information on our income taxes.
If there had been a 1% increase in the global effective income tax rate, the change would have resulted in an approximate $98 million increase in the net deferred income tax asset balance at December 31, 2025. See Notes 1 and 22 of the Notes to the Consolidated Financial Statements for additional information on our income taxes.
See Note 24 of the Notes to the Consolidated Financial Statements for the amount of our unfunded investment commitments at December 31, 2024 and 2023.
See Note 24 of the Notes to the Consolidated Financial Statements for the amount of our unfunded investment commitments at December 31, 2025 and 2024.
Real Estate and Real Estate Joint Ventures Our real estate investments are comprised of wholly-owned properties, and interests in both real estate joint ventures and real estate funds which invest in a wide variety of properties and property types, consisting of single and multi-property projects, and are broadly diversified across multiple property types and geographies.
Real Estate and REJVs Our real estate investments are comprised of wholly-owned properties, and interests in both REJVs and real estate funds which invest in a wide variety of properties and property types, consisting of single and multi-property projects, and are broadly diversified across multiple property types and geographies.
Assuming (i) interest rates follow the observable forward yield curves as of December 31, 2024, including a 10-year U.S.
Assuming (i) interest rates follow the observable forward yield curves as of December 31, 2025, including a 10-year U.S.
We use interest rate derivatives to mitigate gross margin compression for both products. Gross margin compression is limited for our group disability products, which are generally renewable term policies allowing for crediting rate adjustments at renewal based on the retrospective experience rating and the prevailing interest rate assumptions. Rising Interest Rate Scenario .
We use interest rate derivatives to mitigate gross margin compression for both products. 51 Table of Contents Gross margin compression is limited for our group disability products, which are generally renewable term policies allowing for crediting rate adjustments at renewal based on the retrospective experience rating and the prevailing interest rate assumptions. Rising Interest Rate Scenario .
See “Business — Regulation — State Insurance Regulation” and “— MetLife, Inc. — Liquidity and Capital Sources — Dividends from Subsidiaries.” 97 Table of Contents Affiliated Reinsurance Transactions Certain subsidiaries of MetLife, Inc. cede certain products to various affiliated U.S. captive reinsurers and affiliated non-U.S. reinsurers for risk and capital management purposes, as well as to manage statutory reserve requirements.
See “Business — Regulation — State Insurance Regulation” and “— MetLife, Inc. — Liquidity and Capital Sources and Uses — Dividends from Subsidiaries.” Affiliated Reinsurance Transactions Certain subsidiaries of MetLife, Inc. cede certain products to various affiliated U.S. captive reinsurers and affiliated non-U.S. reinsurers for risk and capital management purposes, as well as to manage statutory reserve requirements.
For U.S. dollar denominated products, higher reinvestment rates on cash flows from these products more than offset the negative impacts of (i) higher interest crediting rates on such products, and (ii) lower income from derivative positions designed to protect against a low interest rate environment. MetLife Holdings Declining Interest Rate Scenario.
For U.S. dollar denominated products, higher reinvestment rates on cash flows from these products more than offset the negative impacts of (i) higher interest crediting rates on such products, and (ii) lower income from derivative positions designed to protect against a low interest rate environment.
Years Ended December 31, 2024 2023 (In millions) Adjusted earnings $ 1,606 $ 1,655 Adjusted premiums, fees and other revenues $ 24,870 $ 23,929 Year Ended December 31, 2024 Compared with the Year Ended December 31, 2023 Unless otherwise stated, all amounts discussed below are net of income tax.
Years Ended December 31, 2025 2024 2023 (In millions) Adjusted earnings $ 1,692 $ 1,606 $ 1,655 Adjusted premiums, fees and other revenues $ 25,469 $ 24,870 $ 23,929 Year Ended December 31, 2025 Compared with the Year Ended December 31, 2024 Unless otherwise stated, all amounts discussed below are net of income tax.
MetLife, Inc. lends funds, as necessary, through credit agreements or otherwise to its subsidiaries and affiliates, some of which are regulated, to meet their capital requirements or to provide liquidity. MetLife, Inc. had loans to subsidiaries outstanding of $285 million and $305 million at December 31, 2024 and 2023, respectively.
MetLife, Inc. lends funds, as necessary, through credit agreements or otherwise to its subsidiaries and affiliates, some of which are regulated, to meet their capital requirements or to provide liquidity. MetLife, Inc. had loans to subsidiaries outstanding of $0 and $285 million at December 31, 2025 and 2024, respectively.
The principal cash outflows come from repayments of debt and the collateral financing arrangement, payments of dividends on and repurchases or redemptions of MetLife, Inc.’s securities, withdrawals associated with PABs and the return of securities on loan. 99 Table of Contents Liquidity and Capital Sources Liquidity and capital are provided by a variety of global funding sources, including: (i) preferred and common stock; (ii) short-term debt, which includes commercial paper; (iii) long-term debt; collateral financing arrangement; and junior subordinated debt securities; (iv) PABs, which includes funding agreements; (v) credit and committed facilities; (vi) shelf registration statement, which permits the issuance of public debt, equity and hybrid securities and provides for automatic effectiveness upon filing and has no stated issuance capacity; and (vii) dispositions.
The principal cash outflows come from repayments of debt and the collateral financing arrangement, payments of dividends on and repurchases or redemptions of MetLife, Inc.’s securities, withdrawals associated with PABs and the return of securities on loan. 111 Table of Contents Liquidity and Capital Sources and Uses Liquidity and capital are provided by a variety of global funding sources, including: (i) preferred and common stock; (ii) short-term debt, which includes commercial paper; (iii) issuances of long-term debt, including subordinated debt securities, and collateral financing arrangement; (iv) PABs, which includes funding agreements; (v) credit and committed facilities; (vi) the facility agreement for senior debt issuances: (vii) shelf registration statement, which permits the issuance of public debt, equity and hybrid securities and provides for automatic effectiveness upon filing and has no stated issuance capacity; and (viii) dispositions.
Years Ended December 31, 2024 2023 (In millions) Adjusted earnings $ 1,621 $ 1,282 Adjusted earnings on a constant currency basis $ 1,621 $ 1,248 Adjusted premiums, fees and other revenues $ 6,757 $ 6,969 Adjusted premiums, fees and other revenues on a constant currency basis $ 6,757 $ 6,608 Year Ended December 31, 2024 Compared with the Year Ended December 31, 2023 Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations.
Years Ended December 31, 2025 2024 2023 (In millions) Adjusted earnings $ 1,702 $ 1,621 $ 1,282 Adjusted earnings on a constant currency basis $ 1,702 $ 1,605 $ 1,248 Adjusted premiums, fees and other revenues $ 6,768 $ 6,757 $ 6,969 Adjusted premiums, fees and other revenues on a constant currency basis $ 6,768 $ 6,723 $ 6,608 Year Ended December 31, 2025 Compared with the Year Ended December 31, 2024 Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations.
Years Ended December 31, 2024 2023 (In millions) Adjusted earnings $ 283 $ 265 Adjusted earnings on a constant currency basis $ 283 $ 253 Adjusted premiums, fees and other revenues $ 2,548 $ 2,346 Adjusted premiums, fees and other revenues on a constant currency basis $ 2,548 $ 2,271 Year Ended December 31, 2024 Compared with the Year Ended December 31, 2023 Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations.
Years Ended December 31, 2025 2024 2023 (In millions) Adjusted earnings $ 367 $ 283 $ 265 Adjusted earnings on a constant currency basis $ 367 $ 280 $ 253 Adjusted premiums, fees and other revenues $ 2,901 $ 2,548 $ 2,346 Adjusted premiums, fees and other revenues on a constant currency basis $ 2,901 $ 2,566 $ 2,271 Year Ended December 31, 2025 Compared with the Year Ended December 31, 2024 Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations.
(MetLife Japan) NR NR NR AA- 4th of 21 Metropolitan Tower Life Insurance Company A+ AA- Aa3 AA- 2nd of 16 4th of 19 4th of 21 4th of 21 __________________ NR = Not rated 98 Table of Contents Credit ratings indicate the rating agency’s opinion regarding a debt issuer’s ability to meet the terms of debt obligations in a timely manner.
(MetLife Japan) Not Rated Not Rated Not Rated AA- 4th of 21 Metropolitan Tower Life Insurance Company A+ AA- Aa3 AA- 2nd of 16 4th of 19 4th of 21 4th of 21 Credit ratings indicate the rating agency’s opinion regarding a debt issuer’s ability to meet the terms of debt obligations in a timely manner.
Our sub-prime RMBS portfolio consists predominantly of securities that were purchased at significant discounts to par value and discounts to the expected principal recovery value of these securities, and the vast majority are investment grade under NAIC designations. 87 Table of Contents ABS & CLO Our non-mortgage loan-backed structured securities are comprised of two broad categories of securitizations: ABS & CLO.
Our sub-prime RMBS portfolio consists predominantly of securities that were purchased at significant discounts to par value and discounts to the expected principal recovery value of these securities, and most are investment grade under NAIC designations. 97 Table of Contents ABS & CLO Our non-mortgage loan-backed structured securities are comprised of two broad categories of securitizations: ABS and CLO.
These risks arise from public and private fixed income assets, private loans including real estate, derivative transactions, bank deposits, reinsurance treaties and other similar contracts. • Insurance Risk: is the risk of loss or adverse change in insurance liabilities from changes in the level, trend, and volatility of insurance and policyholder behavior experience varying from best estimate assumptions.
These risks arise from public and private fixed income assets, private loans including real estate, derivative transactions, bank deposits, reinsurance agreements and other similar contracts. 123 Table of Contents • Insurance Risk: is the risk of loss or adverse change in insurance liabilities from changes in the level, trend, and volatility of insurance and policyholder behavior experience varying from best estimate assumptions.
Adjusted Earnings Available to Common Shareholders - Increased $271 million on a reported basis, primarily due to the following business drivers: Reinsurance Transaction - Decreased adjusted earnings available to common shareholders by approximately $170 million as a result of the reinsurance transaction that closed in November 2023 in the MetLife Holdings segment Foreign Currency - Decreased adjusted earnings available to common shareholders by $95 million, primarily in the Latin America and Asia segments Market Factors - Increased adjusted earnings available to common shareholders by $217 million: • Variable investment income increased - higher returns on private equity funds • Recurring investment income increased - higher yields on fixed income securities and mortgage loans, as well as the impact of tax equity investments now accounted for under the proportional amortization method, partially offset by lower income on derivatives and real estate investments Largely offset by: • Higher average interest crediting rates on investment-type and certain insurance products, primarily in the RIS and Asia segments Volume Growth - Increased adjusted earnings available to common shareholders by $194 million: • Higher average invested assets, primarily in the RIS and Latin America segments • Higher sales and business growth in the EMEA and Latin America segments Largely offset by: • Increase in interest credited expenses on long duration products, primarily in the RIS segment 67 Table of Contents Underwriting and Other Insurance Adjustments - Increased adjusted earnings available to common shareholders by $190 million: • Favorable mortality results, primarily in the Group Benefits segment, higher surrender charges in the Asia segment, and favorable morbidity experience in the MetLife Holdings segment, partially offset by unfavorable morbidity experience in the Group Benefits segment • Favorable change from refinements to certain insurance assets and other liabilities in both years, primarily in the Asia and Group Benefits segments, partially offset by an unfavorable change to certain insurance liabilities in the RIS segment Expenses - Decreased adjusted earnings available to common shareholders by $122 million: • Higher direct expenses, including employee-related and technology costs, in most of the segments • Higher litigation reserves Partially offset by: • Lower corporate-related expenses, primarily in Corporate & Other Taxes - Unfavorable change in effective tax rate - 24% in 2024 compared to 22% in 2023: • 2024 effective tax rate on income before provision for income tax was 24% compared to the U.S. statutory rate of 21% primarily due to tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates Partially offset by tax benefits from: ◦ Non-taxable investment income ◦ Low income housing and other tax credits, partially offset by the impact of tax equity investments now accounted for under the proportional amortization method ◦ Corporate tax deduction for stock compensation • 2023 effective tax rate on income before provision for income tax was 22% compared to the U.S. statutory rate of 21% primarily due to tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates Partially offset by tax benefits from: ◦ Low income housing and other tax credits ◦ Non-taxable investment income ◦ Corporate tax deduction for stock compensation 68 Table of Contents Notable Items - Actuarial assumption review and other insurance adjustments, litigation reserves and settlement costs, and tax adjustments - Increased adjusted earnings available to common shareholders by $88 million on a reported basis: Years Ended December 31, Variance 2024 2023 (In millions, net of income tax) Group Benefits $ (58) $ 27 $ (85) RIS 104 61 43 Asia (41) (94) 53 Latin America 4 — 4 EMEA (5) 18 (23) MetLife Holdings 12 2 10 Corporate & Other 10 (76) 86 Total $ 26 $ (62) $ 88 69 Table of Contents Segment Results and Corporate & Other Group Benefits Business Overview.
Adjusted Earnings Available to Common Shareholders - Increased $271 million on a reported basis, primarily due to the following business drivers: Reinsurance Transaction - Decreased adjusted earnings available to common shareholders by approximately $170 million as a result of the reinsurance transaction that closed in November 2023 in Corporate & Other Foreign Currency - Decreased adjusted earnings available to common shareholders by $95 million, primarily in the Latin America and Asia segments Market Factors - Increased adjusted earnings available to common shareholders by $232 million: • Variable investment income increased - higher returns on private equity funds • Recurring investment income increased - higher yields on fixed income securities and mortgage loans, as well as the impact of tax equity investments accounted for under the proportional amortization method in 2024, partially offset by lower income on derivatives and real estate investments Largely offset by: • Higher average interest crediting rates on investment-type and certain insurance products, primarily in the RIS and Asia segments Volume Growth - Increased adjusted earnings available to common shareholders by $189 million: • Higher average invested assets, primarily in the RIS and Latin America segments • Higher sales and business growth in the EMEA and Latin America segments Largely offset by: • Increase in interest credited expenses on long-duration products, primarily in the RIS segment Underwriting and Other Insurance Adjustments - Increased adjusted earnings available to common shareholders by $190 million: • Favorable mortality results, primarily in the Group Benefits segment, higher surrender charges in the Asia segment, and favorable morbidity experience in Corporate & Other, partially offset by unfavorable morbidity experience in the Group Benefits segment • Favorable change from refinements to certain insurance assets and other liabilities in both years, primarily in the Asia and Group Benefits segments, partially offset by an unfavorable change to certain insurance liabilities in the RIS segment 73 Table of Contents Expenses - Decreased adjusted earnings available to common shareholders by $132 million: • Higher direct expenses, including employee-related and technology costs, in most of the segments • Higher litigation reserves Partially offset by: • Lower corporate-related expenses, primarily in Corporate & Other Taxes - Unfavorable change in effective tax rate - 24% in 2024 compared to 22% in 2023: • 2024 effective tax rate on income before provision for income tax was 24% compared to the U.S. statutory rate of 21% primarily due to tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates Partially offset by tax benefits from: ◦ Non-taxable investment income ◦ Low income housing and other tax credits, partially offset by the impact of tax equity investments accounted for under the proportional amortization method in 2024 ◦ Corporate tax deduction for stock compensation • 2023 effective tax rate on income before provision for income tax was 22% compared to the U.S. statutory rate of 21% primarily due to tax charges from: ◦ Foreign earnings taxed at higher statutory rates than the U.S. statutory rate and foreign losses taxed at lower statutory rates Partially offset by tax benefits from: ◦ Low income housing and other tax credits ◦ Non-taxable investment income ◦ Corporate tax deduction for stock compensation Notable Items - Actuarial assumption review and other insurance adjustments, litigation reserves and settlement costs, and tax adjustments - Increased adjusted earnings available to common shareholders by $88 million on a reported basis: Years Ended December 31, Variance 2024 2023 (In millions, net of income tax) Group Benefits $ (58) $ 27 $ (85) RIS 104 61 43 Asia (41) (94) 53 Latin America 4 — 4 EMEA (5) 18 (23) MIM — — — Corporate & Other 22 (74) 96 Total $ 26 $ (62) $ 88 74 Table of Contents Segment Results and Corporate & Other Group Benefits Business Overview.
(3) See MetLife, Inc. (Parent Company Only) Condensed Statements of Cash Flows included in Schedule II of the Financial Statement Schedules for information regarding the source of liquid assets from receipts on loans to subsidiaries (excluding interest) and the use of liquid assets related to the issuances of loans to subsidiaries (excluding interest).
(Parent Company Only) Condensed Statements of Cash Flows included in Schedule II of the Financial Statement Schedules for information regarding the source of liquid assets from receipts on loans to subsidiaries (excluding interest) and the use of liquid assets related to the issuances of loans to subsidiaries (excluding interest).
Certain subsidiaries have pledged assets to secure this debt. (2) Includes $348 million and $442 million of long-term debt that is non-recourse to MetLife, Inc. and MLIC, subject to customary exceptions, at December 31, 2024 and 2023, respectively. Certain investment subsidiaries have pledged assets to secure this debt.
Certain subsidiaries have pledged assets to secure this debt. (2) Includes $411 million and $348 million of long-term debt that is non-recourse to MetLife, Inc. and MLIC, subject to customary exceptions, at December 31, 2025 and 2024, respectively. Certain investment subsidiaries have pledged assets to secure this debt.
Reinsurance adjustments, unless otherwise stated, have been excluded from the amounts within the Investments sections of Management’s Discussion and Analysis of Financial Condition and Results of Operations. See Note 9 of the Notes to the Consolidated Financial Statements for more information about reinsurance.
Reinsurance activity, unless otherwise stated, has been excluded from the amounts within the Investments sections of Management’s Discussion and Analysis of Financial Condition and Results of Operations. See Note 9 of the Notes to the Consolidated Financial Statements for more information about reinsurance.
Investment Commitments We enter into the following commitments in the normal course of business for the purpose of enhancing the total return on our investment portfolio: mortgage loan commitments and commitments to fund partnerships, bank credit facilities, bridge loans and private corporate bond investments.
Investment Commitments We enter into the following commitments in the normal course of business for the purpose of enhancing the total return on our investment portfolio: mortgage loan commitments and commitments to fund partnership investments, bank credit facilities and private corporate bond investments.
For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, an impairment charge would be recognized for the amount by which the carrying value exceeds the reporting unit’s fair value; however, the loss recognized would not exceed the total amount of goodwill allocated to that reporting unit.
For purposes of goodwill impairment testing, if the carrying value of a reporting unit exceeds its estimated fair value, an impairment charge would be recognized for the amount of the difference; however, the loss recognized would not exceed the total amount of goodwill allocated to that reporting unit.
Years Ended December 31, 2024 2023 (In millions) Adjusted earnings $ 881 $ 840 Adjusted earnings on a constant currency basis $ 881 $ 791 Adjusted premiums, fees and other revenues $ 5,936 $ 5,727 Adjusted premiums, fees and other revenues on a constant currency basis $ 5,936 $ 5,392 Year Ended December 31, 2024 Compared with the Year Ended December 31, 2023 Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations.
Years Ended December 31, 2025 2024 2023 (In millions) Adjusted earnings $ 798 $ 881 $ 840 Adjusted earnings on a constant currency basis $ 798 $ 846 $ 791 Adjusted premiums, fees and other revenues $ 6,606 $ 5,936 $ 5,727 Adjusted premiums, fees and other revenues on a constant currency basis $ 6,606 $ 5,751 $ 5,392 Year Ended December 31, 2025 Compared with the Year Ended December 31, 2024 Unless otherwise stated, all amounts discussed below are net of income tax and foreign currency fluctuations.
(4) Other, net includes $46 million and $165 million of net receipts (payments) by MetLife, Inc. to and from subsidiaries under a tax sharing agreement and tax payments to tax agencies for the years ended December 31, 2024 and 2023, respectively.
(4) Other, net includes $103 million and $46 million of net receipts (payments) by MetLife, Inc. to and from subsidiaries under a tax sharing agreement and tax payments to tax agencies for the years ended December 31, 2025 and 2024, respectively.